Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RESCH, KAYLA

NPI: 1083265003 · WARWICK, RI 02886 · Physician Assistant · NPI assigned 09/20/2019

$310K
Total Medicaid Paid
4,147
Total Claims
3,699
Beneficiaries
16
Codes Billed
2020-03
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 609 $31K
2021 1,212 $95K
2022 1,138 $98K
2023 812 $63K
2024 376 $24K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 694 590 $88K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 738 644 $68K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 459 454 $63K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 574 481 $23K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 406 402 $15K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 312 299 $14K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 125 122 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 289 253 $7K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 102 100 $7K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 54 54 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 72 72 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 172 102 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 15 13 $1K
87086 Culture, bacterial; quantitative colony count, urine 42 42 $610.66
81002 80 58 $436.55
81025 13 13 $161.59